HealthcareServices

Sequencing Reagents Industry Insights: Market Forecast to 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Sequencing Reagents Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The sequencing reagents market size has seen rapid expansion in recent years. It is forecast to increase from $10.45 billion in 2024 to $12.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.7%. The growth observed in prior periods can be linked to the incorporation of sequencing in drug discovery and development, governmental efforts to foster genomics research, the expanding uses of sequencing in clinical diagnostics, a rising occurrence of genetic disorders, and the development of precision medicine initiatives.

The sequencing reagents market is anticipated to experience substantial expansion over the next few years, with its size projected to reach $21.71 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.5%. This growth throughout the forecast period can be attributed to several factors, including an increase in cancer genomics research and precision oncology, the proliferation of bioinformatics tools and software for data analysis, escalating investments in genomics research and healthcare infrastructure, the rising demand for personalized medicine, and the broadening applications of sequencing in agriculture and livestock. Significant trends expected during this period include the development of portable and benchtop sequencing platforms, the integration of sequencing with other omics technologies, the creation of novel sequencing reagents for epigenetic analysis, continuous advancements in sequencing technologies, and increasing investments in research and development for new sequencing technologies and reagents.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16184&type=smp

Which Major Market Drivers Are Shaping The Future Of The Sequencing Reagents Market?

The future expansion of the sequencing reagents market is anticipated due to increasing demand and advancements in personalized medicine. Personalized medicine, often referred to as precision medicine, represents a novel medical treatment strategy, customizing healthcare choices and interventions to align with each patient’s unique characteristics. The increasing need for personalized medicine is driven by progress in genomics and molecular diagnostics, allowing for customized therapies that consider individual genetic profiles and disease attributes. Within personalized medicine, sequencing reagents are vital, facilitating the exact analysis of a person’s genetic data for customized diagnostic and therapeutic applications. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that personalized medicines constituted over one-third of new U.S. Food and Drug Administration (FDA) drug approvals for the fourth consecutive year in 2023. Moreover, in 2023, the FDA sanctioned 16 novel personalized therapies for rare disease patients, an increase from six in 2022. Consequently, the growing demand for and evolution of personalized medicine will stimulate the sequencing reagents market.

What Are The Different Segment Classifications Within The Sequencing Reagents Market?

The sequencing reagentsmarket covered in this report is segmented –

1) By Type: Library Kits; Template Kits; Control Kits; Sequencing Kits; Other Types

2) By Technology: Sanger Sequencing; Next Generation Sequencing; Third Generation Sequencing

3) By Application: Oncology; Reproductive Health; Clinical Investigation; Agrigenomics And Forensics; Other Applications

4) By Industry Verticals: Research Institutes; Hospitals and Clinics; Pharmaceutical And Biotechnology Companies; Other Industry Verticals

Subsegments:

1) By Library Kits: Dna Library Kits; Rna Library Kits; Whole Genome Library Kits; Targeted Sequencing Library Kits; Amplicon Library Kits

2) By Template Kits: Dna Template Kits; Rna Template Kits; Cdna Template Kits; Single-Cell Rna Template Kits

3) By Control Kits: Positive Control Kits; Negative Control Kits; Internal Control Kits; Quality Control Kits

4) By Sequencing Kits: Next-Generation Sequencing (Ngs) Kits; Whole Genome Sequencing Kits; Targeted Sequencing Kits; Exome Sequencing Kits; Rna Sequencing Kits

5) By Other Types: Pcr Reagents And Kits; Cloning Kits; Multiplexing Kits; Sanger Sequencing Reagents

What Key Innovation Trends Are Fueling Advancements In The Sequencing Reagents Market?

Major companies operating in the sequencing reagents market are prioritizing the development of innovative technology, such as Illumina Complete Long Read technology, to secure a competitive advantage. Illumina complete long-read technology represents an advanced sequencing approach, integrating the precision and throughput of short-read sequencing with the extensive coverage and ability to traverse complex genomic regions provided by long-read sequencing. As an illustration, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina Complete Long Read Prep, Human. This high-performance, long-read, human whole-genome sequencing (WGS) assay is designed to be compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. Illumina’s Complete Long Read Prep for Humans provides a comprehensive workflow that supports Long Read sequencing of the human genome on Illumina platforms, covering every stage from sample processing to library construction and sequencing. It enables researchers to generate lengthy sequencing reads for in-depth genomic analysis, including the identification of structural variations and complex genomic regions.

Which Major Industry Participants Are Leading The Sequencing Reagents Market Growth?

Major companies operating in the sequencing reagents market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Group, Beckman Coulter Inc., Hamilton Company, GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies (IDT), BioLegend, Twist Bioscience, Diagenode, Covaris Inc., Oxford Nanopore Technologies plc, Biotage, Takara Bio Inc., New England Biolabs (NEB), Pacific Biosciences of California Inc., Zymo Research, Lucigen Corporation, Norgen Biotek Corp., Lexogen GmbH, Daicel Arbor Biosciences, Swift Biosciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report

Which Region Is Projected To Lead The Sequencing Reagents Market During The Forecast Period?

North America was the largest region in the sequencing reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sequencing Reagents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16184&type=smp

Browse Through More Reports Similar to the Global Sequencing Reagents Market 2025, By The Business Research Company

Clinical Oncology Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795